Page last updated: 2024-08-22

vidarabine and Angiofollicular Lymph Hyperplasia

vidarabine has been researched along with Angiofollicular Lymph Hyperplasia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cervigón, I; Palomo, A; Solano, F; Torres-Iglesias, LM; Zapata, AM1

Reviews

1 review(s) available for vidarabine and Angiofollicular Lymph Hyperplasia

ArticleYear
[Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
    Actas dermo-sifiliograficas, 2011, Volume: 102, Issue:4

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Castleman Disease; Cyclophosphamide; Diagnosis, Differential; Drug Resistance, Neoplasm; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemic Infiltration; Male; Middle Aged; Mitoxantrone; Palate, Soft; Red-Cell Aplasia, Pure; Rituximab; Vidarabine

2011
chemdatabank.com